ONUREG

Identification of Onureg

No description

Google image searchProduct monograph

Active ingredient

azacitidine, 300 MG

DIN: 02510200

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 29-FEB-2024

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01B — ANTIMETABOLITES (ATC, ATC/DDD)
• L01BC — Pyrimidine analogues (ATC, ATC/DDD)
• L01BC07 — AZACITIDINE (ATC/DDD)

Reference brand drug: Vidaza

External Links for Onureg

Search on Google

• Onureg side effects
• Onureg dosage
• azacitidine side effects
• azacitidine dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find onureg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.